Prenatal exposure to an NMDA receptor antagonist, MK-801 reduces density of parvalbumin-immunoreactive GABAergic neurons in the medial prefrontal cortex and enhances phencyclidine-induced hyperlocomotion but not behavioral sensitization to methamphetamine in postpubertal rats (original) (raw)
Abekawa T, Honda M, Ito K, Koyama T (2003) Effects of NRA0045, a novel potent antagonist at dopamine D4, 5-HT2A, and α1 adrenaline receptors, and NRA0160, a selective D4 receptor antagonist, on phencyclidine-induced behavior and glutamate release in rats. Psychopharmacology 169:247–256 ArticleCASPubMed Google Scholar
Al-Amin HA, Weickert CS, Weinberger DR, Lipska BK (2001) Delayed onset of enhanced MK-801-induced motor hyperactivity after neonatal lesions of the rat ventral hippocampus. Biol Psychiatry 49:528–539 ArticleCASPubMed Google Scholar
Alcantara S, Ferrer I, Soriano E (1993) Postnatal development of parvalbumin and calbindin D28K immunoreactivities in the cerebral cortex of the rat. Anat Embryol Berl 188:63–73 ArticleCASPubMed Google Scholar
Allen HL, Iversen LL (1990) Phencyclidine, dizocilpine and cerebrocortical neurons. Science 247:221 ArticleCASPubMed Google Scholar
Bailey CDC, Brien JF, Reynolds JN (2001) Chronic prenatal ethanol exposure Increases GABAA receptor subunit protein expression in the adult guinea pig cerebral cortex. J Neurosci 21:4381–4389 CASPubMed Google Scholar
Beasley CL, Reynolds GP (1997) Parvalbumin-immunoreactive neurons are reduced in the prefrontal cortex of schizophrenics. Schizophr Res 24:349–355 ArticleCASPubMed Google Scholar
Beasley CL, Zhang ZJ, Patten I, Reynolds GP (2002) Selective deficits in prefrontal cortical GABAergic neurons in schizophrenia defined by the presence of calcium-binding proteins. Biol Psychiatry 52:708–715 ArticleCASPubMed Google Scholar
Behar TN, Scott CA, Greene CL, Wen X, Smith SV, Maric D, Liu QY, Colton CA, Barker JL (1999) Glutamate acting at NMDA receptors stimulates embryonic cortical neuronal migration. J Neurosci 19:4449–4461 CASPubMed Google Scholar
Benes FM, Bird ED (1987) An analysis of the arrangement of neurons in the cingulate cortex of schizophrenic patients. Arch Gen Psychiatry 44:608–616 CASPubMed Google Scholar
Benes FM, McSparren J, Bird ED, SanGiovanni JP, Vincent SL (1991) Deficits in small interneurons in prefrontal and cingulated cortices of schizophrenic and schizoaffective patients. Arch Gen Psychiatry 48:996–1001 CASPubMed Google Scholar
Benes FM, Vincent SL, Marie A, Khan Y (1996) Up-regulation of GABAA receptor binding on neurons of the prefrontal cortex in schizophrenic subjects. Neuroscience 74:1021–1031 Article Google Scholar
Bogerts B, Ashtari M, Degreef G, Alvir JMJ, Bilder RM, Lieberman JA (1990) Reduced temporal limbic structure volumes on magnetic resonance images in first episode schizophrenia. Psychiatry Res 35:1–13 ArticleCASPubMed Google Scholar
Casey DE, Daniel DG, Wassef AA, Tracy KA, Wolnlak P, Sommerville W (2003) Effect of divalproex combined with olanzapine or risperidone in patients with acute exacerbation of schizophrenia. Neuropsychopharmacology 28:182–192 ArticleCASPubMed Google Scholar
Celio MR (1990) Calbindin D-28K and parvalbumin in the rat nervous system. Neuroscience 35:375–475 ArticleCASPubMed Google Scholar
Corbett R, Camacho F, Woods AT (1995): Antipsychotic agents antagonize non-competitive _N_-methyl-d-aspartate antagonist-induced behaviors. Psychopharmacology 120:67–74 ArticleCASPubMed Google Scholar
Csillik A, Okuno E, Csillik B, Knyihar E, Vecsei L (2002) Expression of kynurenine aminotransferase in the subplate of the rat and its possible role in the regulation of programmed cell death. Cereb Cortex 12:1193–1201 ArticlePubMed Google Scholar
Cunningham MO, Jones RSG (2000) The anticonvulsant, lamotrigine decreases spontaneous glutamate release but increases spontaneous GABA release in the rat entorhinal cortex in vitro. Neuropharmacology 39:2139–2146 ArticleCASPubMed Google Scholar
Demeulemeester H, Vandesande F, Orban GA, Brando C (1988) Heterogenity of GABAergic cells in cat visual cortex. J Neurosci 8:988–1000 CASPubMed Google Scholar
Dursun SM, Deakin JF (2001) Augmenting antipsychotic treatment with lamotrigine or topiramate in patients with treatment-resistant schizophrenia: a naturalistic case-series outcome study. J Psychopharmacol 15:297–301 CASPubMed Google Scholar
Farber NB, Wozniak DF, Price MT, Labruyere J, Huss J, St Peter H, Olney JW (1995) Age-specific neurotoxicity in the rat associated with NMDA receptor blockade: potential relevance to schizophrenia? Biol Psychiatry 38:788–796 ArticleCASPubMed Google Scholar
Freed WJ, Weinberger DR, Bing LA, Wyatt RJ (1980) Neuropharmacological studies of phencyclidine (PCP)-induced behavioral stimulation in mice. Psychopharmacology 71:291–297 ArticleCASPubMed Google Scholar
Gleason SD, Shannon HE (1997) Blockade of phencyclidine-induced hyperlocomotion by olanzapine, clozapine and serotonin receptor subtype selective antagonists in mice. Psychopharmacology 129:79–84 ArticleCASPubMed Google Scholar
Harris LW, Sharp T, Gartlon J, Jones DNC, Harrison PJ (2003) Long-term behavioural, molecular and morphological effects of neonatal NMDA receptor antagonism. Eur J Neurosci 18:1706–1710 ArticlePubMed Google Scholar
Honack D, Loscher W (1993) Sex differences in NMDA receptor mediated responses in rats. Brain Res 620:167–170 ArticleCASPubMed Google Scholar
Javitt DC, Zukin SR (1991) Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 148:1301–1308 CASPubMed Google Scholar
Jentsch JD, Tran A, Taylor JR, Roth RH (1998) Prefrontal cortical involvement in phencyclidine-induced activation of mesolimbic dopamine system: behavioral and neurochemical evidence. Psychopharmacology 138:89–95 ArticleCASPubMed Google Scholar
Kalivas PW, Hooks MS, Sorg B (1993) The pharmacology and neural circuitry of sensitization to psychostimulants. Behav Pharmacol 4:315–334 ArticleCASPubMed Google Scholar
Komuro H, Rakic P (1993) Modulation of neuronal migration by NMDA receptors. Science 260:95–97 ArticleCASPubMed Google Scholar
Lahti AC, Koffel B, LaPorte D, Tamminga CA (1995) Subanesthetic doses of ketamine stimulates psychosis in schizophrenia. Neuropsychopharmacology 13:9–19 ArticleCASPubMed Google Scholar
Leach MJ, Marden CM, Miller AA (1986) Pharmacological studies on lamotrigine, a novel potential antiepileptic drug: II. Neurochemical studies on the mechanism of action. Epilepsia 27:490–497 CASPubMed Google Scholar
Lewis DA, Hashimoto T, Volk DW (2005) Cortical inhibitory neurons and schizophrenia. Neuroscience 6:312–324 CASPubMed Google Scholar
Lipska BK, Luu S, Halim ND, Weinberger DR (2002) Behavioral effects of neonatal And adult excitotoxic lesions of the mediodorsal thalamus in the adult rat. Behav Brain Res 141:105–111 Article Google Scholar
Loscher W (1999) Valproate: a reappraisal of its pharmacodynamic properties and mechanisms of action. Prog Neurobiol 58:31–59 ArticleCASPubMed Google Scholar
Malhotra AK, Adler CM, Kennison SD, Elman I, Picker D, Breier A (1997) Clozapine blunts _N_-methyl-d-aspartate antagonist-induced psychosis: a study with ketamine. Biol Psychiatry 42:664–668 ArticleCASPubMed Google Scholar
Maurel-Remy S, Bervoets K, Millan MJ (1995) Blockade of phencyclidine-induced hyperlocomotion by clozapine and MDL 100,907 in rats reflects antagonism of 5-HT2A receptors. Eur J Pharmacol 280:R9–R11 ArticleCASPubMed Google Scholar
McPhalen CA, Sielecki AR, Santarsiero BD, James MN (1994): refined crystal structure of rat parvalbumin, a mammalian alpha-lineage parvalbumin, at 2.0 A solution. J Mol Biol 235:718–732 ArticleCASPubMed Google Scholar
Mechri A, Saoud M, Khiari G, d’Amato T, Dalery J, Gaha L (2001) Glutamatergic hypothesis of schizophrenia: clinical research studies with ketamine. Encephale 27:53–59 CASPubMed Google Scholar
Metin C, Baudoin JP, Rakic S, Parnavelas JG (2006) Cell and molecular mechanisms involved in the migration of cortical interneurons. Eur J Neurosci 23:894–900 ArticlePubMed Google Scholar
Millan MJ (2005) _N_-methyl-d-aspartate receptors as a target for improved antipsychotic agents: novel insight and clinical perspectives. Psychopharmacology 179:30–53 ArticleCASPubMed Google Scholar
Moore DB, Quintero MA, Ruygrok AC, Walker DW, Heaton MB (1998) Prenatal ethanol exposure reduces parvalbumin-immunoreactive GABAergic neuronal number in the adult rat cingulated cortex. Neurosci Lett 249:25–28 ArticleCASPubMed Google Scholar
Moy SS, Breese GR (2002) Phencyclidine supersensitivity in rats with neonatal dopamine loss. Psychopharmacology 161:255–262 ArticleCASPubMed Google Scholar
Olney JW, Farber NB (1995) Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry 52:998–1007 CASPubMed Google Scholar
Paxinos G, Watson C (1997) The rat brain in stereotaxic coordinates, 3rd edn. Academic, USA Google Scholar
Pierce RC, Kalivas PW (1997) A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res Rev 25:192–216 ArticleCASPubMed Google Scholar
Plogmann D, Celio MR (1993) Intracellular concentration of parvalbumin in nerve cells. Brain Res 600:273–279 ArticleCASPubMed Google Scholar
Robinson TE, Becker JB (1986) Enduring changes in brain and behavior by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res Rev 11:157–198 ArticleCAS Google Scholar
Sadikot AF, Burhan AM, Belanger M-C, Sasseville R (1998) NMDA receptor antagonist influences early development of GABAergic interneurons in the mammalian striatum. Dev Brain Res 105:35–42 ArticleCAS Google Scholar
Sato M, Chen C-C, Akiyama K, Otsuki S (1983) Acute exacerbation of paranoid psychotic state after long-term abstinence in patients with previous methamphetamine psychosis. Biol Psychiatry 18:429–440 CASPubMed Google Scholar
Seiler N, Grauffel C (1992) Antagonism of phencyclidine-induced hyperactivity in mice by elevated brain GABA concentrations. Pharmacol Biochem Behav 41:603–606 ArticleCASPubMed Google Scholar
Sircar R, Soliman KFA (2003) Effects of postnatal PCP treatment on locomotor behavior and striatal D2 receptor. Pharmacol Biochem Behav 74:943–952 ArticleCASPubMed Google Scholar
Szeszko PR, Bilder RM, Lencz T, Pollack S, Alvir JM, Ashtari M, Wu H, Lieberman JA (1999) Investigation of frontal lobe subregions in first-episode schizophrenia. Psychiatry Res 90:1–15 ArticleCASPubMed Google Scholar
Tiihonen J, Hallikainen T, Ryynanen OP, Repo-Tiihonen E, Kotilainen I, Eronen M, Toivonen P, Wahlbeck K (2003) Lamotrigine in treatment-resistant schizophrenia: a randomized placebo-controlled crossover trial. Biol Psychiatry 54:1241–1248 ArticleCASPubMed Google Scholar
Vriend JP, Alexiuk NA (1996) Effects of valproate on amino acid and monoamine concentration in striatum of audiogenic seizure-prone Balb/c mice. Mol Chem Neuropathol 27:307–324 ArticleCASPubMed Google Scholar
Wassef AA, Dott SG, Harris A, Brown A, O’Boyle M, Meyer WJ III, Rose RM (2000) Randomized, placebo-controlled pilot study of divalproex sodium in the treatment of acute exacerbations of chronic schizophrenia. J Clin Psychopharmacol 20:357–361 ArticleCASPubMed Google Scholar
Yonezawa Y, Kuroki T, Kawahara T, Tashiro N, Uchimura H (1998) Involvement of γ-aminobutyric acid neurotransmission in phencyclidine-induced dopamine release in the medial prefrontal cortex. Eur J Pharmacol 341:45–56 ArticleCASPubMed Google Scholar